Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Volume

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Aug 04, 2023 10:43am

237 Views

Post# 35573199

RE:RE:RE:RE:RE:Volume

I happen to hold stocks in CytoDyn Inc. Traded OTC :CYDY Somewhat similar in terms of an early stage Biotech company. CEO and their chosen Clinical Research firm Amarex simply over stated their results. FDA obviously rejected their claims.
SP took a nose dive!!.
The reason for my comparison is that I am glad tha Dr. Mndel and RDW are way more diligent in stating the facts the way it is and not glossing over it for personal gain. I believe we are very close to getting the BTD and may be even AA by Dec, 2023. If that does not happen I will think of an exit strategy. Hopefully We will all have a great Christmas and NewYear.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price